Keep an eye on Closely (2)pentobarbital will minimize the level or influence of suvorexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Sturdy CYP3A4 inducers may possibly decrease suvorexant efficacy; if improved suvorexant dose expected, usually do not exceed 20 mg/daypentobarbital will decrease the level or in… Read More